Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P3
Near historical low
vs 3Y Ago
-28.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -2405.00% |
| Q3 2025 | 122.22% |
| Q2 2025 | -96.54% |
| Q1 2025 | 126.00% |
| Q4 2024 | -4.93% |
| Q3 2024 | -138.25% |
| Q2 2024 | 55.56% |
| Q1 2024 | -2912.50% |
| Q4 2023 | 104.16% |
| Q3 2023 | -28.60% |
| Q2 2023 | 34.00% |
| Q1 2023 | -90.34% |
| Q4 2022 | 83.59% |
| Q3 2022 | -281.25% |
| Q2 2022 | 145.71% |
| Q1 2022 | 12.50% |
| Q4 2021 | -17.65% |
| Q3 2021 | 33.33% |
| Q2 2021 | -13.33% |
| Q1 2021 | 25.00% |
| Q4 2020 | -42.86% |
| Q3 2020 | 67.19% |
| Q2 2020 | -172.34% |
| Q1 2020 | 40.51% |
| Q4 2019 | -71.74% |
| Q3 2019 | 6.12% |
| Q2 2019 | 20.97% |
| Q1 2019 | 18.42% |
| Q4 2018 | -65.22% |
| Q3 2018 | 23.33% |
| Q2 2018 | -25.00% |
| Q1 2018 | -292.00% |
| Q4 2017 | 151.02% |
| Q3 2017 | 7.55% |
| Q2 2017 | 53.91% |
| Q1 2017 | -16.16% |
| Q4 2016 | -3.13% |
| Q3 2016 | -1.05% |
| Q2 2016 | -35.71% |
| Q1 2016 | -29.63% |